Good things are starting to happen now. Following on from the Summatix deal, this raising removes the financing risk (the reason the shares are where they are). The VC backers have doubled down. They won’t be sellers so the register stays tight.
Market cap, fully diluted, is just $6m. Compare that to Propeller which was sold to Resmed for the AUD equivalent of $280m. The medical device adherence space is hot property.
Adherium has refined it’s strategy and the results are starting to become evident. Multi bagger situation.
